All Stories

  1. The Current Status of EMDR Therapy Involving the Treatment of Complex Posttraumatic Stress Disorder
  2. The Status of EMDR Therapy in the Treatment of Posttraumatic Stress Disorder 30 Years After Its Introduction
  3. Theoretical Background and Clinical Aspects of the Use of EMDR in Patients With Bipolar Disorder
  4. Editorial: Present and Future of EMDR in Clinical Psychology and Psychotherapy
  5. A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients
  6. Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population
  7. That which does not kill you-May afflict you? Psychological trauma in bipolar disorder
  8. Meta-analyses of cavum septum pellucidum in mood disorders in comparison with healthy controls or schizophrenia
  9. Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
  10. How Does Eye Movement Desensitization and Reprocessing Therapy Work? A Systematic Review on Suggested Mechanisms of Action
  11. A Non-randomized Controlled Trial of EMDR on Affective Symptoms in Patients With Glioblastoma Multiforme
  12. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables
  13. Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity Study
  14. Eye Movement Desensitization and Reprocessing and Slow Wave Sleep: A Putative Mechanism of Action
  15. Efficacy of Eye Movement Desensitization and Reprocessing in Children and Adolescent with Post-traumatic Stress Disorder: A Meta-Analysis of Randomized Controlled Trials
  16. EMDR beyond PTSD: A Systematic Literature Review
  17. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial
  18. Impact of childhood trauma on cognitive profile in bipolar disorder
  19. Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4-year follow-up study
  20. Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis
  21. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial
  22. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study
  23. Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
  24. Structural and Functional Brain Correlates of Cognitive Impairment in Euthymic Patients with Bipolar Disorder
  25. Surface-based brain morphometry and diffusion tensor imaging in schizoaffective disorder
  26. Brain functional changes in first-degree relatives of patients with bipolar disorder: evidence for default mode network dysfunction
  27. Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review
  28. 25 años de Eye Movement Desensitization and Reprocessing: protocolo de aplicación, hipótesis de funcionamiento y revisión sistemática de su eficacia en el trastorno por estrés postraumático
  29. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome
  30. Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life
  31. Prevalence of cavum vergae in psychosis and mood spectrum disorders
  32. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory
  33. Midline Brain Abnormalities Across Psychotic and Mood Disorders
  34. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder
  35. Prevalence and impact of comorbid alcohol use disorder in bipolar disorder: A prospective follow-up study
  36. Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia
  37. Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S)
  38. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms
  39. Brain functional changes across the different phases of bipolar disorder
  40. The prevalence and effect of life events in 222 bipolar I and II patients: A prospective, naturalistic 4 year follow-up study
  41. Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls
  42. Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder
  43. Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: A randomized, controlled pilot-study
  44. Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM)
  45. A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients
  46. Structural Abnormalities in Schizophrenia: Further Evidence on the Key Role of the Anterior Cingulate Cortex
  47. Treatment adherence in bipolar I and schizoaffective disorder, bipolar type
  48. No effects of eye movements on the encoding of the visuospatial sketchpad and the phonological loop in healthy participants: Possible implications for eye movement desensitization and reprocessing therapy
  49. Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study
  50. Bipolar depressed patients show both failure to activate and failure to de-activate during performance of a working memory task
  51. Differenzialdiagnostik und Psychopharmakotherapie bipolarer Störungen
  52. Deeskalationstechniken und atypische Neuroleptika in der Behandlung der akuten Manie
  53. EMDR Therapy Modulates the Default Mode Network in a Subsyndromal, Traumatized Bipolar Patient
  54. Brain functional abnormality in schizo-affective disorder: an fMRI study
  55. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls – Corrigendum
  56. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls
  57. Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients
  58. Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program
  59. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
  60. First-episode psychosis is characterized by failure of deactivation but not by hypo- or hyperfrontality
  61. Failure of de-activation in the medial frontal cortex in mania: evidence for default mode network dysfunction in the disorder
  62. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder
  63. Lamotrigine: when and where does it act in affective disorders? A systematic review
  64. Abnormal temperament in patients with morbid obesity seeking surgical treatment
  65. An Investigation of Temperamental Traits in Patients With Somatoform Disorder: Do They Belong in the Affective Spectrum?
  66. An Investigation of Temperamental Traits in Patients With Somatoform Disorder: Do They Belong in the Affective Spectrum?
  67. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology
  68. Predictores clínicos del funcionamiento interpersonal en pacientes bipolares
  69. Anticonvulsants in the treatment of aggression in the demented elderly: an update
  70. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
  71. Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?
  72. Myoclonus Provoked by Lamotrigine in a Bipolar Patient
  73. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects
  74. Antiepileptic Drugs and Mood Stability
  75. A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder
  76. Risperidone monotherapy in manic inpatients: An open label, multicentre trial
  77. An Exploratory Open Trial on Safety and Efficacy of the Anticonvulsant Retigabine in Acute Manic Patients
  78. Rezidivprophylaxe bipolarer Erkrankungen
  79. Zotepine loading in acute and severely manic patients: a pilot study
  80. Neurochemical Underpinnings in Bipolar Disorder and Epilepsy
  81. Antiepileptic Drugs in Mood-Disordered Patients
  82. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine
  83. Caffeine has no effect on measures of cortical excitability
  84. EEG Abnormalities Under Treatment with Atypical Antipsychotics: Effects of Olanzapine and Amisulpride as Compared to Haloperidol
  85. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects
  86. The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action
  87. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design
  88. Clozapine as Add-On Medication in the Maintenance Treatment of Bipolar and Schizoaffective Disorders
  89. Clinical Relevance and Treatment Possibilities of Bipolar Rapid Cycling
  90. Klinische Relevanz und Behandlungsmöglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Störung
  91. Central pontine myelinolysis in a patient with anorexia nervosa
  92. Antimanic Efficacy of Topiramate in 11 Patients in an Open Trial With an On-Off-On Design
  93. Nichtletale Wirkung hochtoxischer Amitriptylin-Spiegel nach Suizidversuch
  94. Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen
  95. Dysregulation of ion fluxes in bipolar affective disorder
  96. Bupropion-induced isolated impairment of sensory trigeminal nerve function
  97. Psychopathological Changes Preceding Motor Symptoms in Huntington's Disease: A Report on Four Cases
  98. Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective Psychosis
  99. Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania
  100. Intravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients
  101. Elektrokonvulsionstherapie in der Behandlung der schweren Manie
  102. Treatment of tardive akathisia with clonidine: a case report
  103. Female Genital Disorder as Adverse Symptom of Lamotrigine Treatment